| 1.45 -0.33 (-18.54%) | 11-02 15:53 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.53 |
1-year : | 4.08 |
| Resists | First : | 2.16 |
Second : | 3.5 |
| Pivot price | 1.52  |
|||
| Supports | First : | 0.01 |
Second : | 0 |
| MAs | MA(5) : | 1.83 |
MA(20) : | 1.14 |
| MA(100) : | 0.3 |
MA(250) : | 0.37 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 50.6 |
D(3) : | 52.8 |
| RSI | RSI(14): 62 |
|||
| 52-week | High : | 3.5 | Low : | 0 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ VSEE ] has closed below upper band by 46.2%. Bollinger Bands are 594.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 11 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.7 - 1.72 | 1.72 - 1.73 |
| Low: | 1.01 - 1.02 | 1.02 - 1.03 |
| Close: | 1.62 - 1.64 | 1.64 - 1.66 |
VSee Health, Inc. specializes in delivering virtual healthcare solutions. Their flagship offering, iDoc Telehealth, is specifically designed to manage and coordinate comprehensive care for severely ill individuals within various critical care environments, including neurointensive, cardiac intensive, and general intensive care units (ICUs). This system addresses complex conditions such as stroke, spinal cord injuries, brain trauma, and other severe neurological disorders. Beyond specialized care, their broader telehealth platform provides a modular suite of digital tools, empowering clients to customize solutions to their unique needs. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Thu, 22 Oct 2026
A telehealth provider has relationships with 58 hospitals, VSee Health says. - Stock Titan
Thu, 22 Oct 2026
VSee Health Shareholder Letter - Yahoo Finance
Fri, 25 Sep 2026
VSee Health (OTCPK:VSEE.D) - Stock Analysis - Simply Wall St
Thu, 27 Aug 2026
VSee Health Poised for Growth - Yahoo Finance
Thu, 30 Jul 2026
VSee Health Signs LOI for Healthcare Platform Acquisition Target With Over $35 Million in Annualized Revenue - Yahoo Finance
Tue, 28 Jul 2026
VSee Health Announces Strategic Review as Board Advances Late-Stage Strategic Discussions to Maximize Shareholder Value - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
OTC
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 4.754e+007 (%) |
| Held by Institutions | 14.6 (%) |
| Shares Short | 17 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -8.25e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | -62.6 % |
| Operating Margin | -172.7 % |
| Return on Assets (ttm) | -38.8 % |
| Return on Equity (ttm) | -1 % |
| Qtrly Rev. Growth | 1.581e+007 % |
| Gross Profit (p.s.) | 120 |
| Sales Per Share | 1139.69 |
| EBITDA (p.s.) | 1.715e+007 |
| Qtrly Earnings Growth | -42.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 4.68 |
| Dividend | 0 |
| Forward Dividend | 91480 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|